RESMED INC (RMD) Stock Fundamental Analysis

NYSE:RMD • US7611521078

252.55 USD
+6.82 (+2.78%)
At close: Feb 13, 2026
252.55 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to RMD. RMD was compared to 186 industry peers in the Health Care Equipment & Supplies industry. RMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. RMD has a decent growth rate and is not valued too expensively. Finally RMD also has an excellent dividend rating. With these ratings, RMD could be worth investigating further for dividend and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • RMD had positive earnings in the past year.
  • RMD had a positive operating cash flow in the past year.
  • RMD had positive earnings in each of the past 5 years.
  • Each year in the past 5 years RMD had a positive operating cash flow.
RMD Yearly Net Income VS EBIT VS OCF VS FCFRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.47%, RMD belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
  • RMD has a better Return On Equity (23.51%) than 96.24% of its industry peers.
  • The Return On Invested Capital of RMD (20.84%) is better than 97.85% of its industry peers.
  • RMD had an Average Return On Invested Capital over the past 3 years of 18.06%. This is significantly above the industry average of 8.83%.
  • The last Return On Invested Capital (20.84%) for RMD is above the 3 year average (18.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.47%
ROE 23.51%
ROIC 20.84%
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
RMD Yearly ROA, ROE, ROICRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • RMD's Profit Margin of 27.53% is amongst the best of the industry. RMD outperforms 96.77% of its industry peers.
  • RMD's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 34.11%, RMD belongs to the best of the industry, outperforming 99.46% of the companies in the same industry.
  • RMD's Operating Margin has improved in the last couple of years.
  • The Gross Margin of RMD (60.85%) is better than 62.90% of its industry peers.
  • In the last couple of years the Gross Margin of RMD has remained more or less at the same level.
Industry RankSector Rank
OM 34.11%
PM (TTM) 27.53%
GM 60.85%
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
RMD Yearly Profit, Operating, Gross MarginsRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • RMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, RMD has less shares outstanding
  • Compared to 5 years ago, RMD has more shares outstanding
  • RMD has a better debt/assets ratio than last year.
RMD Yearly Shares OutstandingRMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
RMD Yearly Total Debt VS Total AssetsRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • RMD has an Altman-Z score of 12.67. This indicates that RMD is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 12.67, RMD belongs to the best of the industry, outperforming 92.47% of the companies in the same industry.
  • RMD has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.37, RMD belongs to the best of the industry, outperforming 91.40% of the companies in the same industry.
  • A Debt/Equity ratio of 0.06 indicates that RMD is not too dependend on debt financing.
  • RMD has a Debt to Equity ratio of 0.06. This is in the better half of the industry: RMD outperforms 67.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.37
Altman-Z 12.67
ROIC/WACC2.15
WACC9.67%
RMD Yearly LT Debt VS Equity VS FCFRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 3.06 indicates that RMD has no problem at all paying its short term obligations.
  • RMD has a Current ratio of 3.06. This is comparable to the rest of the industry: RMD outperforms 57.53% of its industry peers.
  • A Quick Ratio of 2.32 indicates that RMD has no problem at all paying its short term obligations.
  • With a Quick ratio value of 2.32, RMD perfoms like the industry average, outperforming 59.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 2.32
RMD Yearly Current Assets VS Current LiabilitesRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.29% over the past year.
  • The Earnings Per Share has been growing by 14.94% on average over the past years. This is quite good.
  • The Revenue has grown by 9.57% in the past year. This is quite good.
  • Measured over the past years, RMD shows a quite strong growth in Revenue. The Revenue has been growing by 11.72% on average per year.
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.39% on average over the next years. This is quite good.
  • Based on estimates for the next years, RMD will show a quite strong growth in Revenue. The Revenue will grow by 8.22% on average per year.
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.39%
Revenue Next Year10.01%
Revenue Next 2Y8.69%
Revenue Next 3Y7.93%
Revenue Next 5Y8.22%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RMD Yearly Revenue VS EstimatesRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
RMD Yearly EPS VS EstimatesRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

  • RMD is valuated rather expensively with a Price/Earnings ratio of 24.57.
  • RMD's Price/Earnings ratio is a bit cheaper when compared to the industry. RMD is cheaper than 78.49% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of RMD to the average of the S&P500 Index (27.97), we can say RMD is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 20.57, RMD is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, RMD is valued cheaper than 80.65% of the companies in the same industry.
  • RMD's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 24.57
Fwd PE 20.57
RMD Price Earnings VS Forward Price EarningsRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 79.03% of the companies in the same industry are more expensive than RMD, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of RMD indicates a rather cheap valuation: RMD is cheaper than 89.78% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.75
EV/EBITDA 17.16
RMD Per share dataRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • RMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • RMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.5
PEG (5Y)1.64
EPS Next 2Y13.39%
EPS Next 3Y11.65%

7

5. Dividend

5.1 Amount

  • RMD has a yearly dividend return of 0.98%, which is pretty low.
  • RMD's Dividend Yield is rather good when compared to the industry average which is at 0.20. RMD pays more dividend than 91.94% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, RMD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.98%

5.2 History

  • On average, the dividend of RMD grows each year by 6.33%, which is quite nice.
  • RMD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • RMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.33%
Div Incr Years12
Div Non Decr Years12
RMD Yearly Dividends per shareRMD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • RMD pays out 22.25% of its income as dividend. This is a sustainable payout ratio.
  • RMD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.25%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
RMD Yearly Income VS Free CF VS DividendRMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RMD Dividend Payout.RMD Dividend Payout, showing the Payout Ratio.RMD Dividend Payout.PayoutRetained Earnings

RESMED INC

NYSE:RMD (2/13/2026, 8:04:00 PM)

After market: 252.55 0 (0%)

252.55

+6.82 (+2.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners65.65%
Inst Owner Change0.27%
Ins Owners0.49%
Ins Owner Change1.71%
Market Cap36.79B
Revenue(TTM)5.40B
Net Income(TTM)1.49B
Analysts74.4
Price Target303.52 (20.18%)
Short Float %7.88%
Short Ratio11.84
Dividend
Industry RankSector Rank
Dividend Yield 0.98%
Yearly Dividend2.12
Dividend Growth(5Y)6.33%
DP22.25%
Div Incr Years12
Div Non Decr Years12
Ex-Date02-12
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.49%
Min EPS beat(2)-1.16%
Max EPS beat(2)2.15%
EPS beat(4)2
Avg EPS beat(4)0.54%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.15%
EPS beat(8)5
Avg EPS beat(8)2.85%
EPS beat(12)8
Avg EPS beat(12)2.12%
EPS beat(16)10
Avg EPS beat(16)1.2%
Revenue beat(2)1
Avg Revenue beat(2)0.14%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)0.91%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)0.91%
Revenue beat(8)5
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)0.61%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)1.71%
PT rev (3m)0.79%
EPS NQ rev (1m)1.14%
EPS NQ rev (3m)1.34%
EPS NY rev (1m)1.23%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)0.74%
Valuation
Industry RankSector Rank
PE 24.57
Fwd PE 20.57
P/S 6.83
P/FCF 20.75
P/OCF 19.26
P/B 5.83
P/tB 12.95
EV/EBITDA 17.16
EPS(TTM)10.28
EY4.07%
EPS(NY)12.28
Fwd EY4.86%
FCF(TTM)12.17
FCFY4.82%
OCF(TTM)13.12
OCFY5.19%
SpS36.98
BVpS43.3
TBVpS19.5
PEG (NY)1.5
PEG (5Y)1.64
Graham Number100.08
Profitability
Industry RankSector Rank
ROA 17.47%
ROE 23.51%
ROCE 25.38%
ROIC 20.84%
ROICexc 25.9%
ROICexgc 63.96%
OM 34.11%
PM (TTM) 27.53%
GM 60.85%
FCFM 32.91%
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
ROICexc(3y)19.85%
ROICexc(5y)20.16%
ROICexgc(3y)47.68%
ROICexgc(5y)50.03%
ROCE(3y)22%
ROCE(5y)22.55%
ROICexgc growth 3Y8.61%
ROICexgc growth 5Y0.25%
ROICexc growth 3Y5.42%
ROICexc growth 5Y4.3%
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.37
Debt/EBITDA 0.2
Cap/Depr 67.31%
Cap/Sales 2.55%
Interest Coverage 53.22
Cash Conversion 93.57%
Profit Quality 119.57%
Current Ratio 3.06
Quick Ratio 2.32
Altman-Z 12.67
F-Score6
WACC9.67%
ROIC/WACC2.15
Cap/Depr(3y)65.59%
Cap/Depr(5y)70.36%
Cap/Sales(3y)2.53%
Cap/Sales(5y)3.12%
Profit Quality(3y)102.06%
Profit Quality(5y)92.37%
High Growth Momentum
Growth
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.39%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%
Revenue Next Year10.01%
Revenue Next 2Y8.69%
Revenue Next 3Y7.93%
Revenue Next 5Y8.22%
EBIT growth 1Y18%
EBIT growth 3Y19.01%
EBIT growth 5Y15.82%
EBIT Next Year27.08%
EBIT Next 3Y13.99%
EBIT Next 5Y11.02%
FCF growth 1Y88.25%
FCF growth 3Y103.78%
FCF growth 5Y18.84%
OCF growth 1Y77.41%
OCF growth 3Y70.86%
OCF growth 5Y16.9%

RESMED INC / RMD FAQ

What is the ChartMill fundamental rating of RESMED INC (RMD) stock?

ChartMill assigns a fundamental rating of 7 / 10 to RMD.


Can you provide the valuation status for RESMED INC?

ChartMill assigns a valuation rating of 5 / 10 to RESMED INC (RMD). This can be considered as Fairly Valued.


What is the profitability of RMD stock?

RESMED INC (RMD) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for RMD stock?

The Price/Earnings (PE) ratio for RESMED INC (RMD) is 24.57 and the Price/Book (PB) ratio is 5.83.


What is the financial health of RESMED INC (RMD) stock?

The financial health rating of RESMED INC (RMD) is 8 / 10.